Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BASE
4476
DELISTED
Couchbase
BASE
| $1.15M | ﹤0.01% |
+36,945
| New | +$1.36M |
|
4477
AEye
LIDR
$53.5M
| $1.15M | ﹤0.01% |
7,001
+5,080
| +264% | +$1.41M |
|
4478
CALL
Alight
ALIT
$374M
| $1.15M | ﹤0.01% |
+5,000
| New | +$1.05M |
|
4479
Caledonia Mining Corp
CMCL
$496M
| $1.15M | ﹤0.01% |
94,859
-67,777
| -42% | -$823K |
|
|
GGPIU
4480
DELISTED
Gores Guggenheim, Inc. Unit
GGPIU
| $1.15M | ﹤0.01% |
107,701
-2,452,537
| -96% | -$25.3M |
|
|
PRO
4481
DELISTED
PROS Holdings
PRO
| $1.15M | ﹤0.01% |
32,311
+1,545
| +5% | +$64.9K |
|
4482
Hawkins
HWKN
$2.51B
| $1.15M | ﹤0.01% |
32,833
+17,520
| +114% | +$606K |
|
4483
SeaStar Medical
ICU
$13.6M
| $1.15M | ﹤0.01% |
456
+90
| +25% | +$223K |
|
|
K
4484
PUT
DELISTED
Kellanova
K
| $1.14M | ﹤0.01% |
19,064
| – | – |
|
|
LDTC
4485
DELISTED
LeddarTech
LDTC
| $1.14M | ﹤0.01% |
233,998
-1,533,514
| -87% | -$7.44M |
|
|
RDUS
4486
DELISTED
Radius Recycling
RDUS
| $1.14M | ﹤0.01% |
26,046
-94,867
| -78% | -$4.59M |
|
|
EUCR
4487
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
| $1.14M | ﹤0.01% |
116,623
+80,000
| +218% | +$780K |
|
|
PTVE
4488
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $1.14M | ﹤0.01% |
90,765
-90,260
| -50% | -$1.22M |
|
|
ACHL
4489
DELISTED
Achilles Therapeutics
ACHL
| $1.13M | ﹤0.01% |
145,529
-50,615
| -26% | -$333K |
|
4490
Cato Corp
CATO
$52.8M
| $1.13M | ﹤0.01% |
68,475
+27,332
| +66% | +$457K |
|
|
NFJ
4491
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.45B
| $1.13M | ﹤0.01% |
+76,411
| New | +$1.17M |
|
|
MEOAU
4492
DELISTED
Minority Equality Opportunities Acquisition Inc. Units
MEOAU
| $1.13M | ﹤0.01% |
+110,000
| New | +$1.12M |
|
|
CZOO
4493
CALL
DELISTED
Cazoo Group Ltd
CZOO
| $1.13M | ﹤0.01% |
222
-45
| -17% | -$844K |
|
|
CNTQU
4494
DELISTED
Chardan NexTech Acquisition 2 Corp. Unit
CNTQU
| $1.13M | ﹤0.01% |
+110,000
| New | +$1.12M |
|
4495
Liberty Latin America Class C
LILAK
$1.66B
| $1.13M | ﹤0.01% |
94,454
-138,053
| -59% | -$1.71M |
|
4496
Greif
GEF
$4.78B
| $1.13M | ﹤0.01% |
17,430
-1,124
| -6% | -$69.6K |
|
|
FSRXU
4497
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
| $1.13M | ﹤0.01% |
114,253
-292,094
| -72% | -$2.9M |
|
4498
Resources Connection
RGP
$146M
| $1.12M | ﹤0.01% |
+71,207
| New | +$1.07M |
|
4499
Clear Secure
YOU
$4.47B
| $1.12M | ﹤0.01% |
27,377
-262,571
| -91% | -$12.3M |
|
4500
PUT
Corning
GLW
$128B
| $1.12M | ﹤0.01% |
30,700
+10,600
| +53% | +$423K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.